ABC | Volume 111, Nº4, Outubro 2018

Artigo de Revisão Oliveira et al Risco-benefício da revascularização carotídea Arq Bras Cardiol. 2018; 111(4):618-625 1. North American Symptomatic Carotid Endarterectomy Trial. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325(7):445-53. 2. Mayberg MR, Wilson SE, Yatsu F,Weiss DG, Messina L, Hershey LA, et al. Carotidendarterectomyandpreventionofcerebral ischemia insymptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991;266(23):3289-94. 3. Warlow CP. Symptomatic patients: the European Carotid Surgery Trial (ECST). J Mal Vasc. 1993;18(3):198-201. 4. Hobson RW, Weiss DG, Fields WS,Goldstone J, Moore WS, Towne JB, et al. et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328(4):221-7. 5. Mayberg MR. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421-8. 6. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491-502. 7. YadavJS,WholeyMH,KuntzRE,etal.Protectedcarotid-arterystentingversus endarterectomy inhigh-riskpatients.NEnglJMed.2004;351(15):1493-501. 8. Mas JL, Trinquart L, Leys D, Albuchen JF, Rousseau H, Viguler A et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7(10):885-92. 9. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7(10):893-902. 10. Brott TG, Hobson RW, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11-23. 11. Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Matzoer DC, et al.et al. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. N Engl J Med. 2016;374(11):1011-20. 12. International Carotid Stenting Study investigators, Ederle J, Dobson J, featherstone RL, Benati LH, van der Worp HB, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985-97. 13. Paraskevas KI, Kalmykov EL, Naylor AR. Stroke/Death Rates Following Carotid Artery Stenting and Carotid Endarterectomy in Contemporary Administrative Dataset Registries: ASystematic Review. Eur J Vasc Endovasc Surg. 2015;51(1):3-12. 14. Naylor AR. Why is the management of asymptomatic carotid disease so controversial? Surgeon. 2015;13(1):34-43. 15. Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, et al. Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke.2015;46(11):3288-301. 16. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association. Circulation. 2017;35(10):e146-e603. 17. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074-84. 18. WritingGroupMembers,MozaffarianD,BenjaminEJ,GoAS,ArnettDK,Blaha MJ,CushmanM,etal.HeartDiseaseandStrokeStatistics-2016UpdateaReport from the American Heart Association. Circulation.2016;133(4):447-54. 19. Padua A De, Favarato D. Original article mortality due to cardiovascular diseases in Brazil and in the metropolitan region of São Paulo : A 2011 Update. Arq Bras Cardiol. 2012;2(99):755-61. 20. Rutherford JD, Pfeffer MA, Moye LA, Davis BR, Flaker GC, Kawey PR, et al. Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular enlargement trial-SAVE Investigators. Circulation. 1994;90:1731-8. 21. Yusuf S, Pepine CJ, Garces C, Pouler H, Salem D, Kostis J, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992;340(8829):1173-8. 22. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, Weaver WD. Angiotensin- Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol. 2006;47(8):1576-83. 23. Montalescot G, Sechtem U, Achenbach S, Achenbach S, Andreotti F, Arden C, et al. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003. 24. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the AmericanCollege of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines, and the American College of Ph. J AmColl Cardiol. 2012;60(24):e44-e164. 25. Cesar LA, Ferreira JF,ArmaganijanD, Gowdak LH, Mansur AP, Bodanese L,C; Sociedade Brasileira de Cardiologia. Diretriz de doença coronária estável. Arq Bras Cardiol. 2014;103(supl 2):1-59. 26. Cholesterol Treatment Triallists(CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland J, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-81. 27. Park SJ, Kang SJ, Ahn JM, Chang M, Yun SC, Roh JH, et al. Effect of Statin Treatment onModifying Plaque Composition ADouble-Blind, Randomized Study. J Am Coll Cardiol. 2016;67(15):1772-83. 28. Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2012-31. 29. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. Guideline on the management of patients with extracranial carotid and vertebral artery disease. Vasc Med. 2011;16(1):35-77. 30. KernanWN, Ovbiagele B, BlackHR, BravataDM, ChimowitzMI, Ezekowitz MD, et al. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the AmericanHeart Association/American Stroke Association. Stroke. 2014;45(7):2160-236. 31. AboyansV,Ricco J-B,BartelinkM-L,BjorckM,BrodmannM,CohnertT,etal. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39(9):763-816. 32. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long- term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572-9. 33. Howard G, Roubin GS, Jansen O, Hendrikse J, Halliday A, Froecrich G, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: Ameta-analysis of pooled patient data from four randomised trials. Lancet. 2016;387(10025):1305-11. Referências 624